Becker's Healthcare February 21, 2025
A group of more than 150 organizations is urging the Trump administration to reverse course on proposed regulations for prescribing controlled substances via telehealth.
In a Feb. 20 letter to Attorney General Pam Bondi, the organizations wrote that the proposed regulations would “limit patient access through requirements that a clinician provide in-person care rather than creating guardrails that more narrowly address the real-world risks of controlled substance diversion.”
In the last days of the Biden administration, the Drug Enforcement Administration and HHS proposed rules to establish a three-tiered system for prescribing controlled substances via telehealth.
The first tier would allow physicians and other qualified clinicians to prescribe schedule III and IV drugs via telehealth. The second would...
Today's Sponsors
Today's Sponsor